Source: International Congress 2016 – Prognostic variables in lung cancer I
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Cheol-Hong Kim (Gyeonggi-do, Republic of Korea), Cheol-Hong Kim, Dong-Gyu Kim, In-Gyu Hyun, Masahiro Seike. Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma. Eur Respir J 2016; 48: Suppl. 60, 2863

Member's Comments

No comment yet.

Related content which might interest you: Tumor laterality influences the prognostic impact of Bcl-2 expression in curatively resected NSCLC patients Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Prognostic significance of MUC1 expression in resected lung adenocarcinoma Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Epidermal growth factor receptor and related biomarkers evaluated by immunohistochemistry in patients with resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Prognostic value of EGFR mutation in NSCLC in surgical stage Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Correlation of bim and noxa expression with clinicopathological features in NSCLC Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Prognostic value and functional characterization of miR-141 and miR-200c expression levels in resected NSCL Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Prognostic significance of p53 and Ki-67 expression in Patients with Resected Lung squamous cell carcinoma Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Prognostic significance of Nestin in resected non-small cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010